Quantitative study of Tom-1 mRNA expression in omental adipose tissue of patients with type 2 diabetes and insulin resistance

( views:130, downloads:0 )
Author:
ZHAO Wei-min()
LIU Zi-min()
ZOU Xiu-lan()
()
()
()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 15, Issue 03, 2007
DOI:
Key Word:

Abstract:

  • [1]郑骄阳,刘志民.应用基因芯片技术观察了2型糖尿病胰岛素抵抗患者脂肪组织受体及信号转导相关基因的改变.第二军医大学学报,2004,24:572-572.
  • [2]Martell M,Gomez J,Esteban J I,et al.High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.J Clin Microbiol,1997,37:327-332.
  • [3]Burk O,Worpenberg S,Haenig B,et al.Tom-1,a novel v-Myb target gene expressed in AMV-and E26-transformed myelomonocytic cells.EMBO J,1997,16:1371-1380.
  • [4]Lohi O,Poussu A,Mao Y,et al.VHS domain-a longshoreman of vesicle lines.FEBS Lett,2002,513:19-23.
  • [5]Megumi Yamakami,Hideyoshi Yokosawa.Tom1(Target of Myb 1)is a novel negative regulator of interleukin-1-and tumor necrosis factor-induced signaling pathways.Biol Pharm Bull,2004,27:564-566.
  • [6]Rome S,Meugnier E,Vidal H.The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling[J].Curr Opin Clin Nutr Metab Care,2004,7:249-254.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn